Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Genome-wide copy number alteration and VEGFA amplification of circulating cell-free DNA as a biomarker in advanced hepatocellular carcinoma patients treated with Sorafenib

Fig. 2

(a) Total cfDNA concentration and (b) VEGFA ratio in healthy controls and HCC patients. A two-tailed Mann-Whitney U test was performed to compare the median values. The horizontal line in the middle of each box indicates the median, and the top and bottom borders of the box mark the 75th and 25th percentiles, respectively. The whiskers above and below the box mark the ranges. Abbreviations: cfDNA, cell-free DNA; VEGFA, vascular endothelial growth factor-A; HCC, hepatocellular carcinoma

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us